SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Neurology (movement disorders) Referral — Muhammad Ali

PatientMuhammad Ali
Date of birth1972-01-17
IdentifiersMRN HR-BX001-SYN; SSN (made up) 000-01-7724
Document date2026-02-10
AuthorCeleste Moreau, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

Young-onset Parkinson's disease, diagnosed twelve years ago at 42, in a 54-year-old man whose slowness of movement now limits daily tasks on a modest levodopa dose. Please review the diagnosis, advise on the levodopa dose or another agent, and plan rehabilitation for his soft speech and gait. [S]

Urgency: Routine, within four weeks, on the same day as his four-week primary care check. [S]

Questions for the consultant:

History of Present Illness

Parkinsonism diagnosed at 42, three years after he retired from professional boxing; at the time it was described as a parkinsonian syndrome possibly related to repeated head blows, and that link has never been settled. On carbidopa-levodopa 25/100 mg one tablet three times daily, often taken with meals, for many years. Today, in the on state: MDS-UPDRS Part III 30, Hoehn and Yahr stage 2.5, with bilateral bradykinesia and rigidity worse on the right, right-hand rest tremor, reduced facial expression and blinking, and soft, monotone speech. No dyskinesia, wearing-off, or freezing. No falls; Timed Up and Go 13 seconds; recovers after three steps on the pull test. Blood pressure 130/80 mmHg supine and 122/78 mmHg standing at 3 minutes. MoCA 27 of 30, PHQ-9 3, EAT-10 2, negative REM sleep behavior disorder and impulse-control screens, and Epworth score 6. Blood count, chemistry, vitamin B12, and TSH normal. No dopamine-blocking drugs [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

3 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Carbidopa-levodopa 25/100 mg oral tablet, one tablet by mouth three times dailyOne tablet by mouth three times daily, at about 7 a.m., noon, and 5 p.m.Oral route2014-10-01 to 2026-03-10completedS

Problems

ProblemClinical statusVerificationCodeProvenance
Parkinson's disease, young onset (diagnosed at 42), Hoehn and Yahr stage 2.5, without dyskinesia or motor fluctuationsactiveconfirmed G20.A1S — Synthetic modern coding of the publicly disclosed diagnosis; the stage and the absence of motor complications are synthetic.
Hypokinetic dysarthria with soft speech due to Parkinson's diseaseactiveconfirmed R47.1S — Synthetic modern coding of the publicly reported speech difficulty; the severity is synthetic.

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1981Professional boxing career with repeated blows to the head, ended by retirement in 1981; whether it caused his Parkinson's disease is disputedR (CLM-0003, CLM-0006)
1984Parkinsonian condition diagnosed in 1984, at 42, by a neurologist in New York, with slowness of movement, a masked face, decreased blinking, tremor, and a shuffling gaitD (CLM-0003, CLM-0004)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-02-10Body height191cmS
2026-02-10Body weight102kgS
2026-02-10Body mass index (BMI) [Ratio]28kg/m2S
2026-02-10Systolic blood pressure128mm[Hg]S
2026-02-10Diastolic blood pressure78mm[Hg]S
2026-02-10Heart rate72/minS
2026-02-10Respiratory rate14/minS
2026-02-10Body temperature36.7CelS
2026-02-10Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-02-10Hemoglobin [Mass/volume] in Blood14.6g/dL13.2-16.6 g/dLNormalS
2026-02-10Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
2026-02-10Potassium [Moles/volume] in Serum or Plasma4.3mmol/L3.5-5.1 mmol/LNormalS
2026-02-10Creatinine [Mass/volume] in Serum or Plasma1.02mg/dL0.74-1.35 mg/dLNormalS
2026-02-10Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M87mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-02-10Glucose [Mass/volume] in Serum or Plasma92mg/dL70-99 mg/dLNormalS
2026-02-10Calcium [Mass/volume] in Serum or Plasma9.5mg/dL8.6-10.3 mg/dLNormalS
2026-02-10Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma512pg/mL232-1245 pg/mLNormalS
2026-02-10Thyrotropin [Units/volume] in Serum or Plasma1.8m[IU]/L0.45-4.5 mIU/LNormalS
2026-02-10Total score [MoCA]27{score}S
2026-02-10Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S

Assessment

Plan of Treatment